307 devices · GMDN 54808
Multiple antinuclear antibody (ANA) screening IVDs use fluorescent immunoassay technology to detect ANAs in patient samples, helping diagnose autoimmune diseases like lupus or rheumatoid arthritis. These kits analyze serum or plasma for markers that indicate systemic autoimmune conditions, supporting early diagnosis and treatment planning.
These devices are typically classified as in vitro diagnostics (IVDs) and regulated under strict quality and performance standards to ensure accuracy and reliability. They are commonly supplied as kits containing reagents, controls, and instructions for use, requiring proper laboratory handling and validation before clinical implementation.
This category summary is AI-generated from the GMDN nomenclature and has not been verified by a human reviewer.